Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study
Conclusion
This study found an association between the use of HF-specific pharmacotherapy and improved clinical outcomes in frail HF hospitalised patients when compared to those who were not on treatment.
Trial registration number
ANZCTRN383195.
Source: BMJ Open - Category: General Medicine Authors: Sharma, Y., Horwood, C., Hakendorf, P., Thompson, C. Tags: Open access, Cardiovascular medicine Source Type: research
More News: Beta-Blockers | Brain | Cardiology | Cardiovascular | General Medicine | Haemorrhagic Fever With Renal Syndrome (HFRS) | Heart | Heart Failure | Neurology | Study